NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $521,523 | +0.1% | 5,120 | -0.9% | 0.29% | -1.4% |
| Q2 2023 | $521,200 | +5.7% | 5,165 | -3.6% | 0.29% | -1.7% |
| Q1 2023 | $493,120 | +3.4% | 5,360 | +2.0% | 0.30% | -1.7% |
| Q4 2022 | $476,734 | +21.6% | 5,255 | +1.9% | 0.30% | +19.8% |
| Q3 2022 | $392,000 | -10.1% | 5,155 | -0.1% | 0.25% | -7.7% |
| Q2 2022 | $436,000 | -2.5% | 5,160 | +1.3% | 0.27% | +18.7% |
| Q1 2022 | $447,000 | +5.2% | 5,095 | +4.8% | 0.23% | +8.5% |
| Q4 2021 | $425,000 | +18.7% | 4,860 | +11.2% | 0.21% | +5.0% |
| Q3 2021 | $358,000 | -8.4% | 4,372 | +2.1% | 0.20% | -3.8% |
| Q2 2021 | $391,000 | +23.7% | 4,282 | +15.9% | 0.21% | +14.1% |
| Q1 2021 | $316,000 | -5.1% | 3,693 | +4.7% | 0.18% | -10.7% |
| Q4 2020 | $333,000 | +20.7% | 3,526 | +11.0% | 0.21% | +3.0% |
| Q3 2020 | $276,000 | +10.0% | 3,176 | +10.6% | 0.20% | -1.5% |
| Q2 2020 | $251,000 | +7.7% | 2,871 | +1.8% | 0.20% | -13.6% |
| Q1 2020 | $233,000 | – | 2,821 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |